![Abbey Jenkins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Abbey Jenkins
Director/Board Member at AQUESTIVE THERAPEUTICS, INC.
Net worth: 10 467 $ as of 2024-04-29
Profile
Abigail L.
Jenkins currently works at Interstitial Cystitis Association of America, Inc., as Director, Aquestive Therapeutics, Inc., as Independent Director from 2024, and XORTX Therapeutics, Inc., as Director from 2024.
Ms. Jenkins also formerly worked at Gamida Cell Ltd., as President, Chief Executive Officer & Director from 2022 to 2024, Medimmune, Inc., as Senior Director-Marketing in 2011, Gamida Cell, Inc., as Director, Aquinox Pharmaceuticals, Inc., as Chief Commercial Officer & Head-US Business, Relypsa, Inc., as Vice- President-Market Access from 2014 to 2016, Allergan Ltd.
(Ireland), as Vice President-Business Development from 2011 to 2013, and Lyndra Therapeutics, Inc., as Chief Commercial & Business Officer from 2021 to 2022.
Ms. Jenkins received her undergraduate degree from Indiana University and graduate degree from The Johns Hopkins University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GAMIDA CELL LTD.
0.38% | 2024-03-14 | 581,527 ( 0.38% ) | 10 467 $ | 2024-04-29 |
Abbey Jenkins active positions
Companies | Position | Start |
---|---|---|
AQUESTIVE THERAPEUTICS, INC. | Director/Board Member | 2024-03-31 |
XORTX THERAPEUTICS INC. | Director/Board Member | 2024-04-07 |
Interstitial Cystitis Association of America, Inc. | Director/Board Member | - |
Former positions of Abbey Jenkins
Companies | Position | End |
---|---|---|
Gamida Cell, Inc.
![]() Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Director/Board Member | 2024-05-23 |
GAMIDA CELL LTD. | Chief Executive Officer | 2024-05-23 |
Lyndra Therapeutics, Inc.
![]() Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 2022-07-31 |
RELYPSA INC | Corporate Officer/Principal | 2016-04-30 |
ALLERGAN PLC | Corporate Officer/Principal | 2013-08-31 |
Training of Abbey Jenkins
Indiana University | Undergraduate Degree |
The Johns Hopkins University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
GAMIDA CELL LTD. | Health Technology |
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
XORTX THERAPEUTICS INC. | Health Technology |
Private companies | 7 |
---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Relypsa, Inc.
![]() Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Allergan Ltd. (Ireland)
![]() Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Medimmune, Inc. | Health Technology |
Interstitial Cystitis Association of America, Inc. | |
Lyndra Therapeutics, Inc.
![]() Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Technology Services |
Gamida Cell, Inc.
![]() Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Health Technology |
- Stock Market
- Insiders
- Abbey Jenkins